Detection of specific antibodies against the SARS-CoV-2 virus in ATG laboratories - Access To Genome
Detection of specific antibodies against the SARS-CoV-2 virus in ATG laboratories – Access To Genome
ATG – Access To Genome laboratories provide the ability to detect specific antibodies in the blood of patients or asymptomatic carriers.
IGG and IGM specific antibodies are tested using Roche’s very high sensitivity and specificity system, Elecsys Anti-SARS-CoV-2. This test enables qualitative detection of total IGG and IGM antibodies with a sensitivity of up to 100% (95% CI 88.1-100) in the 14 days after the positive PCR test and 99.8% specificity (95% CI 99.65 – 99.91).
For more information on the Covid-19 test call us at the following numbers:
Thessaloniki: 2310-433.335 – Athens: 210-72.33.323 & 210-77.77.061